-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, driven by the new medical reform policy, the domestic pharmaceutical industry has gradually upgraded from generic drugs to innovative drugs, and local pharmaceutical companies have accelerated the pace
of innovation and transformation.
At present, in order to further promote the innovation and development of the domestic pharmaceutical industry and provide a stronger talent guarantee, relevant favorable documents and measures are continuously issued from the country and even all localities to vigorously cultivate pharmaceutical talents
.
For example, Qingdao City has issued "Several Measures to Build a Strong City of Traditional Chinese Medicine", spending real money to support the development of
traditional Chinese medicine.
Specifically, in a number of measures, it is clearly stipulated that for the selected municipal leading talents of traditional Chinese medicine, famous traditional Chinese medicine and grassroots famous traditional Chinese medicine practitioners, the monthly financial support of the candidates at the same level shall not be less than 2,000 yuan, 2,000 yuan and 1,500 yuan respectively during the training cycle
.
The studios of famous Chinese medicine experts at or above the provincial level will be given financial support according to the standard of not more than 100,000 yuan per unit; For instructors and heirs included in the national, provincial and municipal Chinese medicine teacher education projects, funding will be given according to the standard of 20,000 yuan per person per year during the training cycle
.
On November 17, the award ceremony of the "Chunsheng Cup" Medical Innovation Talent Competition (2022•Shanghai) and the Shanghai Medical Innovation Summit Forum were held
in the China Financial Information Center.
It is reported that this competition is Shanghai's to further discover and cultivate medical innovation talents, stimulate the transformation of scientific and technological achievements in medical and health institutions, promote the deep integration of medical innovation and industrial resources, and create a medical highland with international influence, under the guidance of the Shanghai Talent Work Leading Group Office, jointly organized by the Shanghai Municipal Health Commission, the Municipal Science and Technology Commission, the Municipal Economic Information Commission, the Municipal Intellectual Property Office, and the Municipal Drug Regulatory Bureau
。 It is reported that in the next step, the Shanghai Municipal Health Commission will also unite multiple forces, play a combined fist, make full use of the "Marine Medical Sheng" innovative talent special fund, implement the special research project for medical innovative talents, create a normalized technological innovation service platform, and jointly issue support policies with relevant commissions and
offices.
In the future, the "Chunsheng Cup" Medical Innovation Talent Competition will be held regularly every year, with the event as the carrier to build Shanghai into a strong magnetic field that gathers top talents in medical innovation and top resources in the field of biomedicine, and creates a better environment and more conditions
for the cultivation of talents in related fields in Shanghai.
In addition, in the "14th Five-Year Plan" for the development of traditional Chinese medicine issued by Henan Province, it was proposed that Henan will continue to improve the education level of Chinese medicine colleges, optimize the talent training mode, and cultivate more outstanding talents
in traditional Chinese medicine 。 The "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Zhuang Yao Medicine" issued by Guangxi also mentioned that it is necessary to consolidate the talent base of Chinese medicine Zhuang Yao medicine.
.
.
It is worth mentioning that in addition to vigorously cultivating talents, many places have launched recruitment orders for talents in the global biomedical industry this yearIn April, Hainan Free Trade Port 2022 (the first batch) of key projects centralized signing meeting, Haikou released 1,510 biomedical industry talent demand positions to the world
.
Specifically, Haikou needs 106 doctoral degrees or above, 130 master's degrees or above, and 727 bachelor's degrees or above; There are 209 R&D positions, 122 senior management positions, 262 inspection and testing positions, and 21 engineering and technical posts
.
From the perspective of annual salary, the salary of high-level talents in the field of biomedicine is between
500,000-3 million yuan.
On March 30, Chengdu High-tech Zone also released the first batch of Golden Panda high-level talent demand list, the first batch of postdoctoral recruitment lists and the construction plan of Chengdu High-tech Zone's high-end talent online service platform in 2022
.
The industry believes that behind the recruitment order for talents in the global biomedical industry in many places, it is also the rapid rise of the pharmaceutical and biological industry in various parts of China, and the urgent need for high-level talents to join, so as to help the high-quality development of the industry
.
In general, with the continuous release of favorable policies for pharmaceutical talents, it will be of great significance to better solve the problems faced by the development of pharmaceutical talents, which will provide a stronger talent guarantee
for the high-quality innovation and development of China's pharmaceutical industry in the future.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.